EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ragweed Major Allergen Amb a 11 Recombinant Production and Clinical Implications

Tudor-Paul Tamaș iD, Maria-Roxana Buzan iD, Lauriana-Eunice Zbîrcea, Monica-Daniela Cotarcă, Manuela Grijincu, Virgil Păunescu, Carmen Panaitescu iD, Kuan-Wei Chen

Biomolecules · 2023

DOI: 10.3390/biom13010182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Tudor-Paul Tamaș und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Immuno-Physiology and Biotechnologies, Department of Functional Sciences, Victor Babes University of Medicine and Pharmacy, 300041 Timișoar…. Hauptthemen laut MEDLINE: Hypersensitivity, Asthma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund under Competitiveness Operational Programme 2014-2020, Priority Axis 1 "Research, Technological Development and Innovation (…, INSPIRED (Innovative Strategies for Prevention, Diagnosis, and Therapy of Ragweed-Pollen-Induced Respiratory Diseases) project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ragweed pollen is highly allergenic and elicits type I hypersensitivity reactions in the exposed populations. Amb a 11 is a recently discovered component of this pollen, and its biological role in allergy is still being researched. In our study, ragweed allergy patients were recruited prospectively over a three-year period; a comprehensive questionnaire was administered, and sera were collected and stored. The production of recombinant Amb a 11 was achieved in parallel with patients’ recruitment. The gene coding for mature protein was inserted in E. coli and in Sf9 Spodoptera frugiperda cells. The recombinant allergens (designated eAmb a 11 and iAmb a 11) were tested for His-tag presence in Western blot. IgE reactivity was evaluated in 150 patients’ sera for both recombinant allergen forms in ELISA, with 5 positive sera being tested further by hRBL (humanized rat basophilic leukemia) hexosaminidase release assay. Both allergen forms were proven to be IgE-reactive His-tagged proteins, with an extensive overlap of positive sera (92 toward the former recombinant allergen, 100 toward the latter) and an overall Amb a 11 sensitization prevalence estimated at 68.67%. The hRBL mediator release assay revealed a significant, slightly weaker effect of recombinant allergens when compared with nAmb a 1. Sensitization to this major allergen appears to be associated with more severe asthma symptoms (OR = 4.71, 95% CI = 1.81–12.21). In conclusion, recombinant Amb a 11 is a bona fide allergen, which is IgE-reactive and an inducer of hRBL degranulation. It is an important IgE-reactive component from ragweed pollen, with high IgE sensitization prevalence in the sample population and allergenicity of the recombinant allergen comparable to Amb a 1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypersensitivityAsthmaRatsAnimalsAllergensAmbrosiaPlant ProteinsEscherichia coliImmunoglobulin ERecombinant Proteins

Stichwörter der Autor:innen

ELISARBL assayclinical featuresrecombinant Amb a 11

Substanzen

AllergensPlant ProteinsImmunoglobulin ERecombinant Proteins

Autor:innen und Institutionen

  • Center of Immuno-Physiology and Biotechnologies, Department of Functional Sciences, Victor Babes University of Medicine and Pharmacy, 300041 Timișoara, Romania.
  • OncoGen Center, "Pius Brînzeu" Timiș County Clinical Emergency Hospital, 300723 Timișoara, Romania.

ORCID-Profile: Tudor-Paul Tamaș, Maria-Roxana Buzan, Carmen Panaitescu

Förderung

  • European Regional Development Fund under Competitiveness Operational Programme 2014-2020, Priority Axis 1 "Research, Technological Development and Innovation (…
  • INSPIRED (Innovative Strategies for Prevention, Diagnosis, and Therapy of Ragweed-Pollen-Induced Respiratory Diseases) project

Zitieren

APA

Tamaș, T. P., Buzan, M. R., Zbîrcea, L. E., Cotarcă, M. D., Grijincu, M., Păunescu, V., Panaitescu, C., & Chen, K. W. (2023). Ragweed Major Allergen Amb a 11 Recombinant Production and Clinical Implications. Biomolecules. https://doi.org/10.3390/biom13010182

Vancouver

Tamaș TP, Buzan MR, Zbîrcea LE, Cotarcă MD, Grijincu M, Păunescu V, et al. Ragweed Major Allergen Amb a 11 Recombinant Production and Clinical Implications. Biomolecules. 2023. doi:10.3390/biom13010182

BibTeX
@article{Tama2023,
  author = {Tamaș, Tudor-Paul and Buzan, Maria-Roxana and Zbîrcea, Lauriana-Eunice and Cotarcă, Monica-Daniela and Grijincu, Manuela and Păunescu, Virgil and Panaitescu, Carmen and Chen, Kuan-Wei},
  title = {Ragweed Major Allergen Amb a 11 Recombinant Production and Clinical Implications},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13010182}
}
Kostenlos starten →